Creative Medical Technology (CELZ) Institutional Ownership → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free CELZ Stock Alerts $4.34 -0.06 (-1.36%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Creative Medical Technology (NASDAQ:CELZ)CurrentInstitutional OwnershipPercentage1.42%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$85.44KNumber ofInstitutional Sellers(last 12 months)0 Get CELZ Insider Trade Alerts Want to know when executives and insiders are buying or selling Creative Medical Technology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… Creative Medical Technology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/25/2024 Aaron Wealth Advisors LLC16,400$85K0.0%N/A1.206% 1/24/2023 Aaron Wealth Advisors LLC100,000$38K0.0%N/A0.710% 5/13/2022 Sassicaia Capital Advisers LLC31,200$122K0.6%N/A0.479% 2/10/2022 Perkins Capital Management Inc.23,750$52K0.0%N/A0.375% (Data available from 1/1/2016 forward) CELZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CELZ shares? During the previous two years, the following institutional investors and hedge funds held shares of Creative Medical Technology shares: Aaron Wealth Advisors LLC ($85K).Learn more on CELZ's institutional investors. What percentage of Creative Medical Technology stock is owned by institutional investors? 1.42% of Creative Medical Technology stock is owned by institutional investors. Learn more on CELZ's institutional investor holdings. Which institutional investors have been buying Creative Medical Technology stock? The following institutional investors have purchased Creative Medical Technology stock in the last 24 months: Aaron Wealth Advisors LLC ($116.40K). How much institutional buying is happening at Creative Medical Technology? Institutional investors have bought a total of 116,400 shares in the last 24 months. This purchase volume represents approximately $466.54K in transactions. Related Companies: Gamida Cell Major Shareholders Finch Therapeutics Group Major Shareholders Genetic Technologies Major Shareholders Inhibikase Therapeutics Major Shareholders Eloxx Pharmaceuticals Major Shareholders Windtree Therapeutics Major Shareholders BioCardia Major Shareholders Coeptis Therapeutics Major Shareholders Tevogen Bio Major Shareholders Senti Biosciences Major Shareholders This page (NASDAQ:CELZ) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.